# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Primary progressive aphasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 171-180 of 189 results.
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand
Status: Recruiting
Last Changed: Apr 27, 2020
First Received: May 22, 2019
Disease(s): Dementia
Intervention(s): 11C-ER176, 11C-PIB
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Natural History Characterization in Symptomatic and Asymptomatic Progranuline Gene Mutation Carriers
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: Jul 10, 2019
Disease(s): Frontotemporal Lobar Degeneration
Intervention(s): Behavioral : Characterization
Locations: Groupe Hospitalier Pitié-Salpêtrière - Charles Foix, Paris, France
Pitié Salpetriere Hospital, Paris, France
Far Infrared Radiation Treatment of Dementia and Other Mental Illness
Status: Unknown status
Last Changed: Aug 17, 2009
First Received: Dec 14, 2007
Disease(s): Dementia
Intervention(s): Far Infrared
Locations: The Centre for Incurable Diseases, Toronto, Ontario, Canada
BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES
Status: Terminated
Last Changed: Dec 19, 2019
First Received: Sep 05, 2018
Disease(s): Primary Tauopathies, Corticobasal Degeneration Syndrome, Frontotemporal Lobar Degeneration With Tau Inclusions, MAPT Mutation Carriers, Symptomatic, Traumatic Encephalopathy Syndrome, Nonfluent Aphasia, Progressive
Intervention(s): BIIB092, Placebo
Locations: UCSF Memory and Aging Center, San Francisco, California, United States
DC Longitudinal Study on Aging and Specimen Bank
Status: Recruiting
Last Changed: Oct 24, 2019
First Received: Oct 11, 2018
Disease(s): Alzheimer Disease, Dementia, Mild Cognitive Impairment, Aging, Aging Disorder
Locations: Georgetown University Memory Disorders Program, Washington, District of Columbia, United States
Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)
Status: Unknown status
Last Changed: Sep 15, 2016
First Received: Oct 29, 2015
Disease(s): Frontotemporal Lobar Degeneration, Amyotrophic Lateral Sclerosis
Intervention(s): characterization
Locations: Groupe Hospitalier Pitié-Salpêtrière - Charles Foix, Paris, France
F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
Status: Completed
Last Changed: Sep 22, 2020
First Received: Apr 10, 2015
Disease(s): Amyotrophic Lateral Sclerosis (ALS)
Intervention(s): Drug: F 18 T807
Locations: Washington University School of Medicine, Saint Louis, Missouri, United States
Diagnosis of Alzheimer's Disease Using Event Related Potentials
Status: Unknown status
Last Changed: Nov 06, 2017
First Received: Nov 06, 2016
Disease(s): Mild Cognitive Impairment
Intervention(s): No intervention is part of this study but patients use an EEG device during observational data collection.
Locations: VA Boston Healthcare, Jamaica Plain, Massachusetts, United States
Molecular and Cellular Mechanisms of Lysosomal Storage Diseases
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: Dec 04, 2013
Disease(s): Lysosomal Storage Disorders
Locations: Lysosomal and Rare Disorders Research and Treatment Center, Inc (LDRTC), Fairfax, Virginia, United States
Double Blind Trial of DC Polarization in FTD
Status: Completed
Last Changed: Jul 02, 2017
First Received: Jul 08, 2005
Disease(s): Dementia
Intervention(s): Anodal DC polarization of left prefrontal cortex
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States